𝔖 Bobbio Scriptorium
✦   LIBER   ✦

763Supplementary treatment with isotretinoin combined with interferon-A-2a in the primary results of a clinical phase-II-study

✍ Scribed by G. Hänsgen; J. Dunst; G. Füchsel; U. Köhler

Book ID
119521760
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
103 KB
Volume
40
Category
Article
ISSN
0167-8140

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a phase-II clinical trial on
Results of a phase-II clinical trial on treatment of rheumatoid arthritis with recombinant interferon-gamma
✍ E. M. Lemmel; M. Franke; W. Gaus; P. W. Hartl; P. H. Hofschneider; K. Miehlke; K 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 552 KB

In an open, non-randomized clinical trial conducted at multiple centres, 49 patients with rheumatoid arthritis were treated with recombinant interferon-gamma for 20 days. The study was carried out in two sub-studies. In the first, the total daily dose of interferon-gamma was 50 micrograms; in the se

Recombinant interferon alfa-2a in advanc
Recombinant interferon alfa-2a in advanced malignant melanoma. a phase i-ii study in combination with dtic
✍ G. R. C. McLeod; D. B. Thomson; P. Hersey 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 384 KB

There is a rising incidence of malignant melanoma world-wide and, despite major improvements in i t s early diagnosis and treatment, the 10-year death rate remains at 20-25%. Evidence that the immune system has a role in the control of melanoma growth has encouraged immunological intervention. The r